Drugs & TargetsFree Keytruda gets accelerated approval based on a genetic feature—first such action May 26, 2017Vol.43 No.21
Drugs & TargetsFree Debiopharm acquires antibody-drug conjugate compound from ImmunoGen May 26, 2017Vol.43 No.21
Drugs & Targets FDA grants regular, accelerated approvals to Keytruda for urothelial carcinoma May 19, 2017Vol.43 No.20
Drugs & Targets FDA grants accelerated approval to avelumab for urothelial carcinoma May 12, 2017Vol.43 No.19
Drugs & Targets Novartis receives FDA approval for Kisqali Femara Co-Pack for initial treatment of HR+/HER2- advanced or metastatic breast cancer May 12, 2017Vol.43 No.19
Drugs & Targets European Commission approves dinutuximab beta for high-risk neuroblastoma May 12, 2017Vol.43 No.19
Drugs & Targets Reolysin gets FDA Fast Track designation for in metastatic breast cancer May 12, 2017Vol.43 No.19
